drugset / Trial / NCT04843098
Study of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety, pharmacokinetic and efficacy of TL117 plus paclitaxel in patients with recurrent or metastatic head and neck cancer.
Timeline
- Start
- 2021-05-26
- Primary completion
- 2024-11-20
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TL117 | Unknown | — | Oral |
| Background | Paclitaxel | Small molecule | 80 mg/m2 | Intravenous |